Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated other comprehensive loss	Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2021		44,248
Beginning balance at Dec. 31, 2021	$ 302,133	$ 15	$ 470,760	$ (587)	$ (168,055)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(54,579)				(54,579)
Issuance of common stock pursuant to exercise of stock options (in shares)		585
Issuance of common stock pursuant to exercise of stock options	1,198	$ 1	1,197
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax (in shares)		705
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax	(4,861)		(4,861)
Restricted stock awards forfeited in connection with transition agreement (in shares)		(140)
Restricted stock awards modified in connection with performance achievement (in shares)		(10)
Issuance of common stock under the Employee Stock Purchase Plan (in shares)		241
Issuance of common stock under the Employee Stock Purchase Plan	2,358		2,358
Stock-based compensation	26,757		26,757
Unrealized gains (losses) on available-for-sale securities	394			394
Cumulative translation adjustment, net of tax	(2,555)			(2,555)
Ending balance (in shares) at Dec. 31, 2022		45,629
Ending balance at Dec. 31, 2022	270,845	$ 16	496,211	(2,748)	(222,634)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(41,670)				(41,670)
Issuance of common stock pursuant to exercise of stock options (in shares)		428
Issuance of common stock pursuant to exercise of stock options	640		640
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax (in shares)		946
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax	(3,968)		(3,968)
Issuance of common stock under the Employee Stock Purchase Plan (in shares)		263
Issuance of common stock under the Employee Stock Purchase Plan	2,469		2,469
Stock-based compensation	25,832		25,832
Unrealized gains (losses) on available-for-sale securities	520			520
Cumulative translation adjustment, net of tax	$ (249)			(249)
Ending balance (in shares) at Dec. 31, 2023	47,266	47,266
Ending balance at Dec. 31, 2023	$ 254,419	$ 16	521,184	(2,477)	(264,304)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (60,792)				(60,792)
Issuance of common stock pursuant to exercise of stock options (in shares)	539	539
Issuance of common stock pursuant to exercise of stock options	$ 500		500
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax (in shares)		840
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax	$ (4,524)		(4,524)
Issuance of common stock under the Employee Stock Purchase Plan (in shares)	303	303
Issuance of common stock under the Employee Stock Purchase Plan	$ 2,721		2,721
Stock-based compensation	24,961		24,961
Unrealized gains (losses) on available-for-sale securities	(181)			(181)
Cumulative translation adjustment, net of tax	$ (674)			(674)
Ending balance (in shares) at Dec. 31, 2024	48,948	48,948
Ending balance at Dec. 31, 2024	$ 216,430	$ 16	$ 544,842	$ (3,332)	$ (325,096)